RxDoctor Payments Data

Bettina Schutzbach, MD

Family Medicine · St Petersburg, FLNPI 1609281245

Payments from drug & device makers

$1,418in general payments, 2019–2025

Across 79 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$402
  • AbbVie$215
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$118
  • Lilly USA, LLC$113
  • Amarin Pharma, Inc.$111
  • Boehringer Ingelheim$99
  • plus $360 from 11 others

What the payments were for

  • Food & beverage$1,40699%
  • Education$121%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,418 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$67,088
Medicare patients
209
Services billed
622

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban31$43,950
OzempicSemaglutide37$38,720
JardianceEmpagliflozin11$13,472
Repatha SureclickEvolocumab16$12,936
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$10,609
Breo ElliptaFluticasone/Vilanterol13$8,137
JanumetSitagliptin Phos/Metformin Hcl11$6,178
Atorvastatin Calcium310$3,111
SynthroidLevothyroxine Sodium33$3,073
Levothyroxine Sodium251$2,561
Losartan Potassium210$2,269
Albuterol Sulfate HfaAlbuterol Sulfate61$2,018
Bupropion XlBupropion Hcl70$1,908
Mirtazapine42$1,899
Omeprazole114$1,530

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$402$38,72037 claims
GSKTrelegy Ellipta, Breo Ellipta$44$18,74629 claims
Boehringer IngelheimJardiance$99$13,47211 claims
MerckJanumet$41$6,17811 claims
AbbVieSynthroid$215$3,07333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in St Petersburg

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →